[Hypofractionated radiotherapy in rectal cancer for elderly patients].
[Hypofractionated radiotherapy in rectal cancer for elderly patients].
Cancer Radiother. 2018 Aug 27;:
Authors: Servagi Vernat S, Guilbert P, Bouché G, Ramiandrisoa F, Bellefqih S
Abstract
Rectal cancer is a common pathology in the elderly. The standard for advanced rectal tumors is a chemoradiotherapy regimen combined 50Gy with concomitant chemotherapy followed by a surgery. This treatment induces interruptions of chemoradiotherapy and toxicities G3-4 more important in people over 70 years of age. Hypofractionated radiotherapy 5×5Gy with surgery following week is an alternative. All retrospective studies on this fractionation report an excellent immediate and chronic tolerance. The randomized phase III NACRE trial, comparing these 2 radiotherapy, followed by surgery at 6-8 week, established a standard in the management of the elderly patients.
PMID: 30166091 [PubMed - as supplied by publisher]
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: Servagi Vernat S, Guilbert P, Bouché G, Ramiandrisoa F, Bellefqih S Tags: Cancer Radiother Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Pathology | Rectal Cancers | Study | Toxicology